Connect
MJA
MJA

Advances in stroke medicine

Bruce CV Campbell
Med J Aust 2020; 212 (1): . || doi: 10.5694/mja2.50433
Published online: 13 January 2020

In reply: I thank Cheng and Richards for highlighting the important role of carotid endarterectomy for high grade symptomatic stenosis in stroke prevention. As this therapy was established in the 1990s,1,2 it was not a focus of the review published in the MJA.3 Nonetheless, carotid endarterectomy is still a central part of the therapeutic armamentarium to reduce the risk of recurrent stroke. The absolute risk reduction in recurrent stroke of about 14% for patients with 70–99% symptomatic stenosis (but not near‐occlusion) observed in the pivotal trials4 may not be as great in contemporary practice with the use of high potency statins and an early combined antiplatelet strategy with aspirin and clopidogrel. This intensive medical therapy is essential in patients with atherosclerotic stroke mechanisms, regardless of whether an endarterectomy is performed, given the risk of recurrent disease and plaque rupture in other regions of the vasculature.

  • Bruce CV Campbell

  • Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC

Correspondence: bruce.campbell@mh.org.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.